Awardee OrganizationALLEGHENY UNIVERSITY OF HEALTH SCIENCES
Description
Abstract Text
Our laboratory has identified a neurotrophic factor active in the
geniculocortical pathway of rats in vivo, and the studies described in this
proposal will utilize this factor to test directly the validity of the
trophic factor hypothesis in the CNS. In particular we will test the idea
that a target-derived molecule is important for the survival and
differentiation of developing neurons of the dorsal lateral geniculate
nucleus (dLGN), as well as the survival of these same neurons after they
mature. In addition, an intensive effort is proposed to scale up
production of this factor (which is already close to purification) for
amino acid sequencing and monoclonal antibody production. This factor is
retrieved in vitro from co-cultures of embryonic rat cortex and
diencephalon; an important finding concerning its role in vivo is that it
is maximally effective in supporting the survival of different sub-
population of developing dLGN neurons - separated from their targets by
cortical lesions -at distinctly different concentrations. In this proposal
we will test in normal rats the role of this factor in maintaining these
dLGN neurons during their period of natural cell death, as well as
determine if the different neuron sub-populations (defined by their time of
origin) also have different concentration requirements for this factor
during this normal cell death period. Concentration-specific requirements
for this factor in order for adult dLGN neurons to survive axotomy will
also be tested in vivo, along with the correlated idea that this
concentration specificity may reflect different rates of factor depletion
in the different sub-populations after axotomy. Finally another important
prediction of the trophic factor hypothesis - that developing neurons
require specific trophic factors in order to differentiate - will be tested
in vitro by determining the effect of different concentrations of the
factor on relationship between the optimal outgrowth-promoting
concentration and the optimal survival-promoting concentration for each
population will be examined.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
UEI
Project Start Date
01-July-1980
Project End Date
31-March-1994
Budget Start Date
01-April-1992
Budget End Date
31-March-1994
Project Funding Information for 1992
Total Funding
$220,743
Direct Costs
$135,425
Indirect Costs
$85,318
Year
Funding IC
FY Total Cost by IC
1992
National Institute of Neurological Disorders and Stroke
$220,743
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS016487-12
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS016487-12
Patents
No Patents information available for 5R01NS016487-12
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS016487-12
Clinical Studies
No Clinical Studies information available for 5R01NS016487-12
News and More
Related News Releases
No news release information available for 5R01NS016487-12
History
No Historical information available for 5R01NS016487-12
Similar Projects
No Similar Projects information available for 5R01NS016487-12